Similar Papers

Paper Title
Journal
Date
Author
SGLT2 inhibitor or GLP-1 receptor agonist in type 2 diabetes?
André J Scheen
The Lancet Diabetes & Endocrinology | VOL. 7
André J ScheenAndré J Scheen
17 Sep 2019
Current and emerging medications for the management of obesity in adults.
Rosalind Walmsley ... Priya Sumithran
The Medical journal of Australia | VOL. 218
Rosalind Walmsley, et. al.Rosalind Walmsley ... Priya Sumithran
19 Mar 2023
Sodium-glucose cotransporter protein-2 (SGLT-2) inhibitors and glucagon-like peptide-1 (GLP-1) receptor agonists for type 2 diabetes: systematic review and network meta-analysis of randomised controlled trials
...
BMJ | VOL. 372
, et. al. ...
13 Jan 2021
Effects of glucagon-like peptide-1 receptor agonists on major cardiovascular events in patients with Type 2 diabetes mellitus with or without established cardiovascular disease: a meta-analysis of randomized controlled trials.
Fabio Marsico ... Paola Gargiulo
European Heart Journal | VOL. 41
Fabio Marsico, et. al.Fabio Marsico ... Paola Gargiulo
20 Feb 2020
View more papers

More From: American Journal of Preventive Cardiology

Paper Title
Journal
Date
Author
Coronary plaque characteristics quantified by artificial intelligence-enabled plaque analysis: Insights from a multi-ethnic asymptomatic US population
Guadalupe Flores Tomasino ... Damini Dey
American Journal of Preventive Cardiology | VOL. -
Guadalupe Flores Tomasino, et. al.Guadalupe Flores Tomasino ... Damini Dey
01 Jan 2025
Comparing the association of novel Anthropometric and atherogenicity indices with all-cause, cardiovascular and non-cardiovascular mortality in a general population of Iranian adults
Parisa Hajihashemi ... Nizal Sarrafzadegan
American Journal of Preventive Cardiology | VOL. -
Parisa Hajihashemi, et. al.Parisa Hajihashemi ... Nizal Sarrafzadegan
01 Jan 2025
Biomarkers of residual risk and all-cause mortality after acute coronary syndrome.
Anna Toso ... Francesco Bellandi
American Journal of Preventive Cardiology | VOL. -
Anna Toso, et. al.Anna Toso ... Francesco Bellandi
01 Jan 2025
Effect of glucagon-like peptide-1 receptor agonists on vascular risk factors among adults with type 2 diabetes and established atherosclerotic cardiovascular disease
Aaron King ... Adam De Havenon
American Journal of Preventive Cardiology | VOL. -
Aaron King, et. al.Aaron King ... Adam De Havenon
01 Jan 2025
View more papers

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.